Blog
Keep up to date with the latest news from Instem.
What the FDA Webcast Revealed About SEND (and Why It Matters)
“For the first time, the FDA openly acknowledged that they are rejecting some SEND datasets because the quality isn’t good enough. No ambiguity. Just a clear statement that quality matters, and that poor SEND has...
d-wise Appoints 2x-CEO, ex-Labcorp Head of Software Solutions to Drive Next Phase of Strategy & Growth
BOSTON, USA – 21 April 2026: d-wise (an Instem company), a leader in statistical computing infrastructure and clinical trial transparency, today announced the appointment of Christine Oliver as its President. Christine brings over two decades...
Instem Taps ex-Novartis Head of Emerging Technologies to Put Science Behind Practical AI and NAMs
Instem, a leading provider of SaaS solutions for preclinical R&D, today announced the appointment of Szczepan Baran, VMD, MS, as Chief Scientific Officer. In the role, Szczepan will lead scientific and AI strategy across in...
The Journey of a Molecule – IND Package Preparation
Complete, Compliant, and SEND‑Ready Submissions for Regulatory Success
Enhancing Reporting, Telemetry, and Signal Processing for Physiological Research with NOTOCORD-hem 5.2
Targeted enhancements across the entire physiological workflow, from acquisition to analysis to Excel-based reporting.
The Journey of a Molecule – CMC Readiness
Ensuring Quality, Traceability, and Compliance
The Journey of a Molecule – Toxicology
Accelerating Preclinical Safety with Connected Data and Predictive Insights
Seamless Document Control with eQCM
By unifying workflows, standardizing processes, and embedding real-time oversight, eQCM transforms document management into a controlled, transparent, and efficient system.
Webinar Recap: Advanced Colony Management with Climb™
In this recap, we cover how Climb can support robust animal management, from breeding strategies and essential housing logistics, to adverse event tracking and real-time veterinary alerts.
